Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib

Autor: Mansfield, A.S., Murphy, S.J., Harris, F.R., Robinson, S.I., Marks, R.S., Johnson, S.H., Smadbeck, J.B., Halling, G.C., Yi, E.S., Wigle, D., Vasmatzis, G. *, Jen, J.
Zdroj: In Annals of Oncology November 2016 27(11):2111-2117
Databáze: ScienceDirect